|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Research and development | |||||
| General and administrative | |||||
| Transaction-related costs | |||||
| Amortization of acquired intangibles | |||||
| Lease and other restructuring charges | |||||
| Total operating expenses | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Interest and other income | |||||
| Interest and other expense | |||||
| Gain on extinguishment of debt | |||||
| Total other income, net | |||||
| Income (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net income (loss) | |||||
| Other comprehensive income (loss): | |||||
| Unrealized gain (loss) on available-for-sale investments | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive income (loss) | |||||
| Net income (loss) per common share | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...